Difference between revisions of "Workshop on Clinical Trial Ontology"

From NCBO Wiki
Jump to navigation Jump to search
m
 
(76 intermediate revisions by 6 users not shown)
Line 1: Line 1:
== General Information ==
+
== '''General Information''' ==
 
 
'''<big>REGISTRATION FOR THIS EVENT IS NOW CLOSED!</big>'''
 
  
 
The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.  
 
The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.  
Line 11: Line 9:
 
We are grateful to the National Heart, Lung and Blood Institute for generous support for this meeting.
 
We are grateful to the National Heart, Lung and Blood Institute for generous support for this meeting.
  
== Aim of the Workshop ==
+
== '''Aim of the Workshop''' ==
  
 
The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.  
 
The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.  
  
The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements.
+
The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements. It will address the potential uses of CTO, and methodology for CTO design and development.
  
== Goals of the Clinical Trial Ontology Initiative==
+
== '''Goals of the Clinical Trial Ontology Initiative''' ==
  
 
The proposed CTO should:
 
The proposed CTO should:
Line 23: Line 21:
 
(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design
 
(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design
  
(2) comprehend terms like: ''cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, experimental design,'' etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC [http://www.cdisc.org/glossary/clinicalterminologyv4.pdf glossary] and  
+
(2) comprehend terms like: ''cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, confounder,'' etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC [http://www.cdisc.org/glossary/clinicalterminologyv4.pdf glossary] and  
 
all terms needed for the task of meta-analysis of clinical trials;  
 
all terms needed for the task of meta-analysis of clinical trials;  
  
Line 38: Line 36:
 
-- the [http://rctbank.ucsf.edu/ontology/outline/index.htm RCT Schema] ontology used by the[http://rctbank.ucsf.edu/ Trial Bank Initiative]
 
-- the [http://rctbank.ucsf.edu/ontology/outline/index.htm RCT Schema] ontology used by the[http://rctbank.ucsf.edu/ Trial Bank Initiative]
  
(7) rest on a clear understanding of the relation between CTO and an epidemiology study ontology
+
(7) rest on a clear understanding of the relation between CTO and related ventures such as an epidemiology study ontology
 +
 
 +
(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG
 +
 
 +
(9) be created through an open process, in which all interested parties can be involved.
 +
 
 +
== '''Agenda''' ==
 +
 
 +
'''<big><u>Wednesday, May 16 - Building 45 (Natcher), Balcony A</u></big>'''
 +
 
 +
* 8:00am -- Registration & Continental Breakfast
  
(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG.
+
'''Session 1 (Chair: Barry Smith)'''
  
(9) meet the requirements of the [http://obofoundry.org OBO Foundry], and in particular support an adequate treatment of the distinction between ''types'' (''surgical intervention'', ''tumor'', ''human being'') and ''instances'' (Jane's oophorectomy, John's tumor, Fritz)
+
* 9:00am -- Carol Bean: ''Introduction''
  
== Agenda ==
+
* 9:10am -- Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: ''Welcome''
  
'''''<big>PLEASE ALLOW AN EXTRA 30 MINUTES TO COMPLETE THE NIH ADMISSON SECURITY PROCESS</big>'''''
+
* 9:20am -- Werner Ceusters: ''How to Build an Ontology'' [http://ontology.buffalo.edu/07/CTO/ceusters.ppt ppt]
  
'''<big><u>May 16  Natcher Balcony A</u></big>'''
+
* 10:00am -- Discussion
  
8:00am  Continental Breakfast & Registration
+
* 10:15am -- Refreshment Break
  
9:00am  Carol Bean: ''Introduction''
+
'''Session 2 (Chair: Dave Parrish)'''
  
9:10am  Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: ''Welcome''
+
* 10:30am -- Chris Mungall: ''The OBO Foundry'' [http://ontology.buffalo.edu/07/CTO/mungall.ppt ppt]
  
9:20am  Werner Ceusters: ''How to Build an Ontology''
+
* 11:00am -- Jennifer Fostel: ''The Ontology for Biomedical Investigations'' [http://ontology.buffalo.edu/07/CTO/fostel.ppt ppt]
  
10:00am Discussion
+
* 11:30am -- Richard Scheuermann: ''Introducing the Clinical Trial Ontology'' [http://ontology.buffalo.edu/07/CTO/scheuermann.ppt ppt]
  
10:15am  Refreshment Break
+
* 12:00pm -- Discussion
  
10:30am  Chris Mungall: ''The OBO Foundry''
+
* 12:30pm -- Lunch Break
  
11:00am  Jennifer Fostel: ''The Ontology for Biomedical Investigations''  
+
'''Session 3 (Chair: Werner Ceusters)'''
  
11:30am  Richard Scheuermann: ''Introducing the Clinical Trial Ontology''
+
* 1:30pm -- Ida Sim: ''The RCT Schema'' [http://ontology.buffalo.edu/07/CTO/sim.ppt  ppt]
  
12:00pm Discussion
+
* 2:00pm -- Amar Das: ''Epoch: An Ontological Framework for Clinical Trial Management''
 +
[http://ontology.buffalo.edu/07/CTO/Das.pdf ppt]
  
12:30pm  Lunch Break
+
* 2:30pm -- Barry Smith: ''The Clinical Trial Ontology: Creating Consensus'' [http://ontology.buffalo.edu/07/CTO/smith.ppt ppt]
  
1:30pm Ida Sim: ''The RCT Schema''
+
* 3:30pm -- Refreshment Break
  
2:00pm Amar Das: ''Epoch: An Ontological Framework for Clinical Trial Management''
+
* 4:00pm -- Discussion Session
  
2:30pm  Barry Smith: ''The Clinical Trial Ontology: Creating Consensus''
+
* 5:00pm -- Close
  
3:30pm  Refreshment Break
 
  
4:00pm  Discussion Session
+
'''<big><u>Thursday, May 17 - Building 31, Conference Room 10</u></big>'''
  
5:00pm  Close
+
* 8:00am -- Registration & Continental Breakfast
  
 +
'''Session 4 (Moderator: Jennifer Fostel)'''
  
 +
* 9:00am -- Building the Clinical Trial Ontology
  
'''<big><u>May 17  Building 31 Conference Room 10</u></big>'''
+
* 10:30am -- Refreshment Break
  
8:00am  Continental Breakfast & Registration
+
''' Session 5 (Moderator: Alan Ruttenberg)'''
  
9:00am Session 1: ''Building the Clinical Trial Ontology''
+
* 11:00am -- Applying the Clinical Trial Ontology
 +
**Norbert Graf: ACGT's Clinical Trial Builder [http://ontology.buffalo.edu/07/CTO/graf.ppt ppt]
  
(Moderator: Richard Scheuermann)
+
* 12:30pm -- Lunch Break
  
10:30am  Refreshment Break
+
'''Session 6 (Moderator: Richard Scheuermann)'''
  
11:00am  Session 2: ''Applying the Clinical Trial Ontology''
+
* 1:30pm -- The Future of the Clinical Trial Ontology [[Media:CTO_Workshop_Day_2_RS_JL.doc]]
  
(Moderator: Alan Ruttenberg)
+
* 3:00pm -- Close
  
12:30pm  Lunch Break
+
== '''NIH Security Regulations''' ==
  
1:30pm Session 3: ''The Future of the Clinical Trial Ontology''
+
All visitor vehicles, including taxicabs, hotel and airport shuttles, delivery trucks and vans will be inspected before being allowed on campus. Visitors will be asked to show a form of government-issued photo identification (driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure. Employees and visitors should continue to wear their identification prominently at all times while on campus.
 +
   
 +
Guards will remain at certain buildings to address specific program requirements such as sensitive research and safety concerns. At building entrances where guards are posted:
 +
* Visitors may be required to log in, wear a visitors pass and have an employee escort them through the building.
 +
* Visitors may be required to pass through a metal detector and have bags, backpacks or purses inspected or x-rayed as they enter buildings.
 +
Security staff will be looking for and confiscating any suspicious or potentially dangerous materials. U.S. Code prohibits bringing any dangerous weapons onto Federal property, including anything with a blade longer than 2½ inches. Meeting participants may want to leave extra bags or personal materials at their hotel to minimize the time needed for inspection.
  
(Moderator: Richard Scheuermann)
+
All visitors including patients, contractors, vendors and delivery persons must use the following entrances:
 +
 +
<u>Rockville Pike at South Drive</u> (Metro):  
 +
* Open 24 hours - Inbound and Outbound traffic
 +
* Open to All Vehicles
 +
* Pedestrian Turnstiles Open for Employees
 +
* Gateway Center at Metro Open for Visitor Registration--this is where visitors check-in with security if they are not driving
  
3:00pm Refreshments/Close
+
<u>Old Georgetown Road at Center Drive</u> (This entrance is primarily for commercial vehicles and visitors):
 +
* 6am- 7pm -Inbound and Outbound Traffic
 +
* Open to Employee, Commercial and Visitor Vehicles
 +
* Pedestrian Turnstiles Open for Employees
 +
   
 +
Please note: Visitor parking is limited at NIH. Visitors are encouraged to use public transportation such as the Metrorail subway system which has a convenient stop (Medical Center) on the NIH campus.
  
== Registered Participants ==
+
Visitors arriving by bus will be dropped off at the NIH/Medical Center Metro stop at Rockville Pike and South Drive. Patients and visitors on official business can then ride the Campus Shuttle to the Clinical Center and other designated shuttle stops on the campus.
  
Robert Arp -- NCBO, Buffalo, NY
+
== '''Participants (Final)''' ==
  
Pat Avery -- Digital Infusion, Inc.
+
Robert Arp -- NCBO, University at Buffalo
  
 
Elaine Ayres -- NIH / Clinical Center
 
Elaine Ayres -- NIH / Clinical Center
  
William Barrick -- NIH/NIAID
+
William Barrick -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
  
Carol Bean -- NIH/NHLBI
+
Carol Bean -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
Maureen Beanan -- NIH/National Center for Research Resources
+
Maureen Beanan -- National Center for Research Resources (NCRR) / NIH
  
 
Elmer Bernstam -- University of Texas Health Science Center at Houston
 
Elmer Bernstam -- University of Texas Health Science Center at Houston
  
Olivier Bodenreider -- NIH/NLM
+
Olivier Bodenreider -- National Library of Medicine (NLM) / NIH
  
Olga Brazhnik -- NIH/National Center for Research Resources
+
Olga Brazhnik -- National Center for Research Resources (NCRR) / NIH
  
 
Constantino Castillo -- The KEVRIC Company, Inc.
 
Constantino Castillo -- The KEVRIC Company, Inc.
Line 132: Line 159:
 
Werner Ceusters -- Ontology Research Group, University at Buffalo
 
Werner Ceusters -- Ontology Research Group, University at Buffalo
  
Huey Cheung -- NIH/CIT
+
Huey Cheung -- Center for Information Technology (CIT) / NIH
 +
 
 +
Ling Chin -- National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH
  
Ling Chin -- NIH / National Institute on Deafness and Other Communication Disorders
+
In Hye Cho -- National Library of Medicine (NLM) / NIH
  
Chris Chute -- NCBO, Mayo Clinic, Rochester, MN
+
Christopher G. Chute -- NCBO, Mayo Clinic
  
Christian Cocos -- IFOMIS, Saarbrücken, Germany
+
Kevin Clany -- Invitrogen Corp.
  
Elaine Collier -- NIH/National Center for Research Resources
+
Christian Cocos -- IFOMIS (Saarbrücken, Germany)
  
Leo Cousineau -- Information Management Consultants, Reston, VA
+
Elaine Collier -- National Center for Research Resources (NCRR) / NIH
  
Lindsay Cowell -- Duke University
+
Leo Cousineau -- Information Management Consultants (Reston, VA)
 +
 
 +
Lindsay Cowell -- Duke University Medical Center
  
 
Amar Das -- Stanford Medical Informatics
 
Amar Das -- Stanford Medical Informatics
Line 153: Line 184:
  
 
Liju Fan -- Ontology Workshop, LLC
 
Liju Fan -- Ontology Workshop, LLC
 +
 +
Gabriele Feolo -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
 
Kerstin Forsberg -- AstraZeneca
 
Kerstin Forsberg -- AstraZeneca
Line 160: Line 193:
 
Douglas Fridsma -- University of Pittsburgh
 
Douglas Fridsma -- University of Pittsburgh
  
Charles P. Friedman -- NIH/CRIIT/NHLBI
+
Jane Fun -- Contractor, National Library of Medicine (NLM) / NIH
  
 
Louis J. Goldberg -- University at Buffalo
 
Louis J. Goldberg -- University at Buffalo
  
Peter Good -- NIH/National Human Genome Research Institute
+
Peter Good -- National Human Genome Research Institute (NHGRI) / NIH
 
 
Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University, Homburg, Germany
 
  
Lakshmi M. Grama -- NIH/NCI
+
Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University (Homburg, Germany)
  
Ted Grasela -- Cognigen Corporation, Amherst, NY
+
Lakshmi M. Grama -- National Cancer Institute (NCI) / NIH
  
Patricia Haggerty -- National Heart, Lung and Blood Institute NHLBI / NIH
+
Ted Grasela -- Cognigen Corporation (Amherst, NY)
  
 
Herb Hagler -- University of Texas Southwestern Medical Center
 
Herb Hagler -- University of Texas Southwestern Medical Center
  
Andrea Harabin -- National Heart, Lung and Blood Institute NHLBI / NIH
+
Andrea Harabin -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
William Harlan -- Consultant, National Library of Medicine / NIH
+
William Harlan -- Consultant, National Library of Medicine (NLM) / NIH
  
 
Steve Harris -- Computing Laboratory, University of Oxford
 
Steve Harris -- Computing Laboratory, University of Oxford
  
Calvin A. Johnson -- Center for Information Technology CIT / NIH
+
Frank Hartel -- NCI Center for Bioinformatics / NIH
 +
 
 +
Calvin A. Johnson -- Center for Information Technology (CIT) / NIH
 +
 
 +
Heather A. Junkins -- CRIIT & NHLBI / NIH
 +
 
 +
Webster Kelsey -- Dept of Biomedical Informatics, University of Pittsburgh
  
 
Warren A. Kibbe -- Northwestern University
 
Warren A. Kibbe -- Northwestern University
  
William Lau -- Center for Information Technology CIT / NIH
+
Bron W. Kisler -- Clinical Data Interchange Standards Consortium (CDISC)
 +
 
 +
George A. Komatsoulis -- NCI Center for Bioinformatics / NIH
 +
 
 +
Jennie Larkin -- National Heart, Lung and Blood Institute (NHLBI) / NIH
 +
 
 +
William Lau -- Center for Information Technology (CIT) / NIH
  
Jamie Lee -- University of Texas Southwestern Medical Center
+
Jamie Lee -- University of Texas Southwestern Medical Center at Dallas
  
 
Natasha Levenkov -- Rockefeller University
 
Natasha Levenkov -- Rockefeller University
Line 194: Line 237:
 
Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH
 
Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH
  
Dan Lyman -- Information Management Consultants, Reston, VA
+
Yun Lu -- KAI Research, Inc.
 +
 
 +
Dan Lyman -- Information Management Consultants (Reston, VA)
 +
 
 +
Peter Lyster -- Center for Bioinformatics and Computational Biology, National Institute of General Medical Sciences (NIGMS) / NIH
 +
 
 +
Peter Maccallum -- CRUK Cambridge Research Institute, University of Cambridge
  
Charles Mead -- NIH/NCI Center for Biomedical Informatics and Information Technology  
+
Charles Mead -- NCI/NIH, Center for Biomedical Informatics and Information Technology  
  
Ivan Montoya -- National Institute on Drug Abuse (NIDA) / NIH
+
Chris Mungall -- NCBO, Lawrence Berkeley National Laboratory
  
Chris Mungall -- Howard Hughes Institute, Berkeley, CA
+
Robert A. Musson -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
Robert A. Musson -- NIH / NHLBI
+
Darren Natale -- Georgetown University Medical Center
  
 
Fabian Neuhaus -– National Institute of Standards and Technology (NIST)
 
Fabian Neuhaus -– National Institute of Standards and Technology (NIST)
  
Eric Neumann -- Teranode, Seattle, WA
+
Eric Neumann -- Teranode (Seattle, WA)
 +
 
 +
Eduardo Ortiz -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
 
Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH
 
Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH
  
Dave Parrish -- Immune Tolerance Network, Pittsburgh, PA
+
Dave Parrish -- Immune Tolerance Network (Pittsburgh, PA)
 
 
Ricardo Pietrobon -- Duke University Medical Center
 
  
 
George O. Redmond -- National Cancer Institute (NCI) / NIH
 
George O. Redmond -- National Cancer Institute (NCI) / NIH
  
Alexander Rosenthal -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
+
Dianne M. Reeves -- National Cancer Institute, Center for Biomedical Informatics and Information Technology (formerly NCICB) / NIH
  
 
Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)
 
Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)
  
Laurie M. Ryan -- National Institute on Aging (NIA) / NIH
+
Jody Sachs -- National Center for Research Resources (NCRR) / NIH
 
 
Jody Sachs -- NIH/National Center for Research Resources
 
  
Michael Sayre -- NIH/National Center for Research Resources
+
Michael Sayre -- National Center for Research Resources (NCRR) / NIH
  
 
Richard Scheuermann -- University of Texas Southwestern Medical Center
 
Richard Scheuermann -- University of Texas Southwestern Medical Center
  
Susan Shurin -- National Heart, Lung and Blood Institute NIH / NHLBI
+
Susan Shurin -- National Heart, Lung and Blood Institute (NHLBI) / NIH  
  
Hua-Chuan Sim -- National Library of Medicine NIH / NLM
+
Hua-Chuan Sim -- National Library of Medicine (NLM) / NIH  
  
 
Ida Sim -- Trial Bank, University of California at San Francisco Medical Center
 
Ida Sim -- Trial Bank, University of California at San Francisco Medical Center
  
Barry Smith -- NCBO, University at Buffalo, NY
+
Barry Smith -- NCBO, University at Buffalo
  
Ranjana Srivastava -- Information Management Consultants, Reston, VA
+
Ranjana Srivastava -- Information Management Consultants (Reston, VA)
  
 
Samson Tu -- Stanford University
 
Samson Tu -- Stanford University
Line 244: Line 291:
 
Chunhua Weng -- University of Pittsburgh
 
Chunhua Weng -- University of Pittsburgh
  
Trish Whetzel -- University of Pennsylvania
+
Rebecca Williams -- National Library of Medicine (NLM) / NIH
  
Rebecca Williams -- National Library of Medicine / NIH
+
Ashley Xia -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
  
Sandhya Xirasagar -- Information Management Consultants, Reston, VA
+
Sandhya Xirasagar -- Information Management Consultants (Reston, VA)
  
Alison Yao -- National Institute of Allergy and Infectious Diseases, NIH / NIAID
+
Alison Yao -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
  
== Venue ==
+
Zhensheng Zhang -- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH
 +
 
 +
== '''Venue''' ==
  
 
Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD
 
Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD
Line 258: Line 307:
 
Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD
 
Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD
  
[http://www.nih.gov/about/visitor/index.htm Travel to NIH Campus]
+
A printable NIH Visitors Map can be found at: [http://parking.nih.gov/documents/visitorAccessMap.pdf NIH Visitors Map]
 +
 
 +
A printable schedule of shuttle service between area hotels and NIH can be found at:  [http://dtts.ors.od.nih.gov/documents/south_hotel_shuttles.pdf NIH Shuttles]
  
== Links ==
+
== '''Links''' ==
  
 
[http://www.bioontology.org/ncbo/faces/index.xhtml NCBO Bioportal]
 
[http://www.bioontology.org/ncbo/faces/index.xhtml NCBO Bioportal]
Line 288: Line 339:
 
The second half of this presentation pertains to the building of the Clinical Trial Ontology.
 
The second half of this presentation pertains to the building of the Clinical Trial Ontology.
  
== Preliminary Fragment of CTO (for illustration purposes only) ==
+
== '''Preliminary Fragment of CTO''' (for illustration purposes only) ==
  
 
[http://cto.googlecode.com/svn/trunk/CTO.owl Current OWL version]
 
[http://cto.googlecode.com/svn/trunk/CTO.owl Current OWL version]
  
 
[[Image:CTO.jpg]]
 
[[Image:CTO.jpg]]

Latest revision as of 10:38, 6 August 2008

General Information

The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.

The meeting will be divided into two parts. Day 1 will be a public event consisting of presentations and panel discussions on the CTO and cognate initiatives. Day 2 will be a working meeting devoted to intense discussions of mature drafts of the CTO and to the creation of a strategy for its further development and testing.

The work of the NCBO is funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant 1 U 54 HG004028. Information on the National Centers for Biomedical Computing can be found here.

We are grateful to the National Heart, Lung and Blood Institute for generous support for this meeting.

Aim of the Workshop

The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.

The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements. It will address the potential uses of CTO, and methodology for CTO design and development.

Goals of the Clinical Trial Ontology Initiative

The proposed CTO should:

(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design

(2) comprehend terms like: cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, confounder, etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC glossary and all terms needed for the task of meta-analysis of clinical trials;

(3) organize these terms in a structured way, providing definitions and logical relations designed to enhance retrieval of, reasoning with, and integration of the data annotated in its terms.

(4) support trial bank interoperation

(5) form an integral part of the more comprehensive framework of the Ontology for Biomedical Investigations OBI, which itself forms part of the OBO Foundry

(6) draw on and seek maximal alignment with existing clinical trial ontologies, including:

-- the Epoch ontology used by the Immune Tolerance Network

-- the RCT Schema ontology used by theTrial Bank Initiative

(7) rest on a clear understanding of the relation between CTO and related ventures such as an epidemiology study ontology

(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG

(9) be created through an open process, in which all interested parties can be involved.

Agenda

Wednesday, May 16 - Building 45 (Natcher), Balcony A

  • 8:00am -- Registration & Continental Breakfast

Session 1 (Chair: Barry Smith)

  • 9:00am -- Carol Bean: Introduction
  • 9:10am -- Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: Welcome
  • 9:20am -- Werner Ceusters: How to Build an Ontology ppt
  • 10:00am -- Discussion
  • 10:15am -- Refreshment Break

Session 2 (Chair: Dave Parrish)

  • 10:30am -- Chris Mungall: The OBO Foundry ppt
  • 11:00am -- Jennifer Fostel: The Ontology for Biomedical Investigations ppt
  • 11:30am -- Richard Scheuermann: Introducing the Clinical Trial Ontology ppt
  • 12:00pm -- Discussion
  • 12:30pm -- Lunch Break

Session 3 (Chair: Werner Ceusters)

  • 1:30pm -- Ida Sim: The RCT Schema ppt
  • 2:00pm -- Amar Das: Epoch: An Ontological Framework for Clinical Trial Management

ppt

  • 2:30pm -- Barry Smith: The Clinical Trial Ontology: Creating Consensus ppt
  • 3:30pm -- Refreshment Break
  • 4:00pm -- Discussion Session
  • 5:00pm -- Close


Thursday, May 17 - Building 31, Conference Room 10

  • 8:00am -- Registration & Continental Breakfast

Session 4 (Moderator: Jennifer Fostel)

  • 9:00am -- Building the Clinical Trial Ontology
  • 10:30am -- Refreshment Break

Session 5 (Moderator: Alan Ruttenberg)

  • 11:00am -- Applying the Clinical Trial Ontology
    • Norbert Graf: ACGT's Clinical Trial Builder ppt
  • 12:30pm -- Lunch Break

Session 6 (Moderator: Richard Scheuermann)

  • 3:00pm -- Close

NIH Security Regulations

All visitor vehicles, including taxicabs, hotel and airport shuttles, delivery trucks and vans will be inspected before being allowed on campus. Visitors will be asked to show a form of government-issued photo identification (driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure. Employees and visitors should continue to wear their identification prominently at all times while on campus.

Guards will remain at certain buildings to address specific program requirements such as sensitive research and safety concerns. At building entrances where guards are posted:

  • Visitors may be required to log in, wear a visitors pass and have an employee escort them through the building.
  • Visitors may be required to pass through a metal detector and have bags, backpacks or purses inspected or x-rayed as they enter buildings.

Security staff will be looking for and confiscating any suspicious or potentially dangerous materials. U.S. Code prohibits bringing any dangerous weapons onto Federal property, including anything with a blade longer than 2½ inches. Meeting participants may want to leave extra bags or personal materials at their hotel to minimize the time needed for inspection.

All visitors including patients, contractors, vendors and delivery persons must use the following entrances:

Rockville Pike at South Drive (Metro):

  • Open 24 hours - Inbound and Outbound traffic
  • Open to All Vehicles
  • Pedestrian Turnstiles Open for Employees
  • Gateway Center at Metro Open for Visitor Registration--this is where visitors check-in with security if they are not driving

Old Georgetown Road at Center Drive (This entrance is primarily for commercial vehicles and visitors):

  • 6am- 7pm -Inbound and Outbound Traffic
  • Open to Employee, Commercial and Visitor Vehicles
  • Pedestrian Turnstiles Open for Employees

Please note: Visitor parking is limited at NIH. Visitors are encouraged to use public transportation such as the Metrorail subway system which has a convenient stop (Medical Center) on the NIH campus.

Visitors arriving by bus will be dropped off at the NIH/Medical Center Metro stop at Rockville Pike and South Drive. Patients and visitors on official business can then ride the Campus Shuttle to the Clinical Center and other designated shuttle stops on the campus.

Participants (Final)

Robert Arp -- NCBO, University at Buffalo

Elaine Ayres -- NIH / Clinical Center

William Barrick -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Carol Bean -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Maureen Beanan -- National Center for Research Resources (NCRR) / NIH

Elmer Bernstam -- University of Texas Health Science Center at Houston

Olivier Bodenreider -- National Library of Medicine (NLM) / NIH

Olga Brazhnik -- National Center for Research Resources (NCRR) / NIH

Constantino Castillo -- The KEVRIC Company, Inc.

Werner Ceusters -- Ontology Research Group, University at Buffalo

Huey Cheung -- Center for Information Technology (CIT) / NIH

Ling Chin -- National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH

In Hye Cho -- National Library of Medicine (NLM) / NIH

Christopher G. Chute -- NCBO, Mayo Clinic

Kevin Clany -- Invitrogen Corp.

Christian Cocos -- IFOMIS (Saarbrücken, Germany)

Elaine Collier -- National Center for Research Resources (NCRR) / NIH

Leo Cousineau -- Information Management Consultants (Reston, VA)

Lindsay Cowell -- Duke University Medical Center

Amar Das -- Stanford Medical Informatics

Kaushal Desai -- AstraZeneca

Stephen Dobson -- Pfizer Global Research and Development

Liju Fan -- Ontology Workshop, LLC

Gabriele Feolo -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Kerstin Forsberg -- AstraZeneca

Jennifer Fostel -- NIH/NIEHS

Douglas Fridsma -- University of Pittsburgh

Jane Fun -- Contractor, National Library of Medicine (NLM) / NIH

Louis J. Goldberg -- University at Buffalo

Peter Good -- National Human Genome Research Institute (NHGRI) / NIH

Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University (Homburg, Germany)

Lakshmi M. Grama -- National Cancer Institute (NCI) / NIH

Ted Grasela -- Cognigen Corporation (Amherst, NY)

Herb Hagler -- University of Texas Southwestern Medical Center

Andrea Harabin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

William Harlan -- Consultant, National Library of Medicine (NLM) / NIH

Steve Harris -- Computing Laboratory, University of Oxford

Frank Hartel -- NCI Center for Bioinformatics / NIH

Calvin A. Johnson -- Center for Information Technology (CIT) / NIH

Heather A. Junkins -- CRIIT & NHLBI / NIH

Webster Kelsey -- Dept of Biomedical Informatics, University of Pittsburgh

Warren A. Kibbe -- Northwestern University

Bron W. Kisler -- Clinical Data Interchange Standards Consortium (CDISC)

George A. Komatsoulis -- NCI Center for Bioinformatics / NIH

Jennie Larkin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

William Lau -- Center for Information Technology (CIT) / NIH

Jamie Lee -- University of Texas Southwestern Medical Center at Dallas

Natasha Levenkov -- Rockefeller University

Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH

Yun Lu -- KAI Research, Inc.

Dan Lyman -- Information Management Consultants (Reston, VA)

Peter Lyster -- Center for Bioinformatics and Computational Biology, National Institute of General Medical Sciences (NIGMS) / NIH

Peter Maccallum -- CRUK Cambridge Research Institute, University of Cambridge

Charles Mead -- NCI/NIH, Center for Biomedical Informatics and Information Technology

Chris Mungall -- NCBO, Lawrence Berkeley National Laboratory

Robert A. Musson -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Darren Natale -- Georgetown University Medical Center

Fabian Neuhaus -– National Institute of Standards and Technology (NIST)

Eric Neumann -- Teranode (Seattle, WA)

Eduardo Ortiz -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH

Dave Parrish -- Immune Tolerance Network (Pittsburgh, PA)

George O. Redmond -- National Cancer Institute (NCI) / NIH

Dianne M. Reeves -- National Cancer Institute, Center for Biomedical Informatics and Information Technology (formerly NCICB) / NIH

Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)

Jody Sachs -- National Center for Research Resources (NCRR) / NIH

Michael Sayre -- National Center for Research Resources (NCRR) / NIH

Richard Scheuermann -- University of Texas Southwestern Medical Center

Susan Shurin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Hua-Chuan Sim -- National Library of Medicine (NLM) / NIH

Ida Sim -- Trial Bank, University of California at San Francisco Medical Center

Barry Smith -- NCBO, University at Buffalo

Ranjana Srivastava -- Information Management Consultants (Reston, VA)

Samson Tu -- Stanford University

Suresh Varghese -- Digital Infuzion, Inc.

Chunhua Weng -- University of Pittsburgh

Rebecca Williams -- National Library of Medicine (NLM) / NIH

Ashley Xia -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Sandhya Xirasagar -- Information Management Consultants (Reston, VA)

Alison Yao -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Zhensheng Zhang -- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH

Venue

Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD

Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD

A printable NIH Visitors Map can be found at: NIH Visitors Map

A printable schedule of shuttle service between area hotels and NIH can be found at: NIH Shuttles

Links

NCBO Bioportal

Open Biomedical Ontologies

OBO Foundry

Ontology for Biomedical Investigations

Trial Bank

Epoch Ontology

The ACGT Project: Advancing Clinico-Genomic Trials on Cancer

Clinical Trial Ontology Wiki

HCLS Ontology Task Force

A video introduction to ontologies by Barry Smith is available here:

  • Realmedia: rtsp://stream.buffalo.edu/shared/research/phismith/Stanford10-25-06/Tutorial.rm
  • Mediaplayer: rtsp://stream.buffalo.edu/shared/research/phismith/Stanford10-25-06/Tutorial.WMV

The second half of this presentation pertains to the building of the Clinical Trial Ontology.

Preliminary Fragment of CTO (for illustration purposes only)

Current OWL version

CTO.jpg